Robin Vacha - 31 Jan 2022 Form 4 Insider Report for Azenta, Inc. (AZTA)

Role
SVP, GM Life Science Products
Signature
/s/ Jason W. Joseph, Attorney-in-fact for Robin Vacha
Issuer symbol
AZTA
Transactions as of
31 Jan 2022
Net transactions value
+$19,748
Form type
4
Filing time
02 Feb 2022, 16:29:31 UTC
Previous filing
19 Nov 2021
Next filing
17 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AZTA Common Stock Award $19,748 +285 +1.2% $69.29 23,217 31 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Purchase by Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Exchange Act") pursuant to Rule 16b-3(c) under the Exchange Act